Dyne Therapeutics, Inc.
DYN
$9.57
-$0.48-4.78%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -42.63% | -34.54% | -41.51% | -36.08% | -45.67% |
| Total Depreciation and Amortization | 8.62% | 0.00% | -3.16% | -1.58% | -1.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.81% | 116.51% | 113.11% | 111.04% | 106.06% |
| Change in Net Operating Assets | 595.36% | -174.09% | 87.45% | 138.81% | -83.42% |
| Cash from Operations | -45.47% | -55.38% | -33.29% | -25.48% | -46.71% |
| Capital Expenditure | -358.84% | -225.93% | -18.61% | 31.19% | 63.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 84.04% | -340.00% | -307.03% | -209.63% | -203.89% |
| Cash from Investing | 81.57% | -344.96% | -312.00% | -212.55% | -206.18% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 25.09% | 1,390.92% | 782.49% | 766.93% | 555.56% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 25.09% | 1,390.92% | 782.49% | 766.93% | 555.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 121.21% | 720.39% | 2,847.34% | 1,291.43% | 176.20% |